Expanding access to safe, quality medicines to achieve universal health coverage in Africa
Organised by United States Pharmacopeia.
Global health progress depends on safe, quality medicines reaching the people who need them the most. But around the world, substandard and falsified medicines are harming patients, costing economies billions of dollars, undermining trust in health systems and accelerating antimicrobial resistance. Hosted by United States Pharmacopoeia (USP), this session will focus on the role of governments and key stakeholders in the life-course of a medicine and how the strength of a health system can determine whether patients receive safe, quality medicines and achieve UHC in Africa.
The session will feature a dynamic panel discussion that traces the “life-course” of a medicine from production to patient. It will seek to elevate the importance of safe, quality medicines through the vision for a world where all have access to beneficial medicines. Furthermore, this session will bring together key stakeholders working in the Africa region to raise awareness and lay the groundwork for greater attention, investment and action around medicines quality.